A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Adult Patients Receiving Standard of Care Antibiotics for the Treatment of Staphylococcus aureus Bloodstream Infections (Bacteremia),

Administered By

Awarded By

Contributors

Start/End

  • November 30, 2020 - December 31, 2026